Wordt geladen...
SAT-476 Alemtuzumab Induced Graves Disease
Introduction: Immune reconstitution therapy (IRT) with the monoclonal antibody alemtuzumab (anti-CD 52) has been shown to be superior to β-interferon in relapsing-remitting multiple sclerosis. It can cause early hyper-population of immature B cells which increases the risk of autoimmune disorders. T...
Bewaard in:
| Gepubliceerd in: | J Endocr Soc |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7209673/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.745 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|